NCT02959463 2026-05-27Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant MesotheliomaM.D. Anderson Cancer CenterPhase 1 Completed25 enrolled 11 charts
NCT02399371 2026-05-08Pembrolizumab in Treating Patients With Malignant MesotheliomaUniversity of ChicagoPhase 2 Completed65 enrolled 12 charts